据报道,睡眠呼吸紊乱(SDB)的患病率很高。在SDB中,阻塞性睡眠呼吸暂停(OSA)的发病率比以前认为的要高,不仅在西方国家,而且在东方国家,患有中度至重度OSA的患者约占成年男性的20%和绝经后女性的10%。包括日本。自1998年以来,当健康保险开始提供时,使用持续气道正压通气(CPAP)治疗睡眠呼吸暂停的患者数量急剧增加,在日本,患者人数将超过50万。尽管“成人睡眠呼吸暂停综合征(SAS)的诊断和治疗指南”于2005年发布,但根据最新趋势制定了新的指南,以表明标准的医疗保健。由日本呼吸学会和“难治性呼吸系统疾病和肺动脉高压调查和研究”小组监督并合作,卫生部,劳动和福利及其他相关学术团体,包括日本睡眠研究学会,除了参考以前的指南。由于睡眠呼吸暂停是一个涵盖许多领域的跨学科领域,本指南包括36个临床问题(CQs).在英文版中,SAS的治疗和管理,显示了从CQ16到36的写作。日本版本于2020年7月发布,并于2021年7月在日本作为医疗信息网络分发服务(Minds)临床实践指南之一发布。
The prevalence of sleep-disordered breathing (SDB) is reportedly very high. Among SDBs, the incidence of obstructive sleep apnea (OSA) is higher than previously believed, with patients having moderate-to-severe OSA accounting for approximately 20% of adult males and 10% of postmenopausal women not only in Western countries but also in Eastern countries, including Japan. Since 1998, when health insurance coverage became available, the number of patients using continuous positive airway pressure (CPAP) therapy for sleep apnea has increased sharply, with the number of patients about to exceed 500,000 in Japan. Although the \"
Guidelines for Diagnosis and Treatment of Sleep Apnea Syndrome (SAS) in Adults\" was published in 2005, a new
guideline was prepared to indicate the standard medical care based on the latest trends, as supervised by and in cooperation with the Japanese Respiratory Society and the \"Survey and Research on Refractory Respiratory Diseases and Pulmonary Hypertension\" Group, of Ministry of Health, Labor and Welfare and other related academic societies, including the Japanese Society of Sleep Research, in addition to referring to the previous
guidelines. Since sleep apnea is an interdisciplinary field covering many areas, this
guideline was prepared including 36 clinical questions (CQs). In the English version, therapies and managements for SAS, which were written from CQ16 to 36, were shown. The Japanese version was published in July 2020 and permitted as well as published as one of the Medical Information Network Distribution Service (Minds) clinical practice
guidelines in Japan in July 2021.